Back to News
Market Impact: 0.4
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
Source: globenewswire.com
Healthcare & BiotechProduct LaunchesRegulation & Legislation
The European Commission approved Ubeslo (obicetrapib monotherapy) and Evlarco (obicetrapib plus ezetimibe fixed-dose combination), marking the first worldwide regulatory approval of obicetrapib. The approval is a positive regulatory milestone for the products; the announcement gives no sales outlook or financial estimates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.65
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Voters rebuff data centers in every ballot measure except one during the 2026 midterms
- China Blocks SoftBank Acquisition of ABB Robot Unit, FT Says
- After the midterms, a bigger clash over data centers could be coming
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- After the midterms, Big Tech’s AI data center problem is only getting bigger